Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

Movement Disorders : Official Journal of the Movement Disorder Society
Paolo LambertiPaolo Livrea

Abstract

Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). The mechanism underlying HHcy in PD is the O-methylation of levodopa catalyzed by catechol-O-methyltransferase (COMT) that produces S-adenosylhomocysteine, which is hydrolyzed rapidly to Hcy. COMT inhibitors (COMT-I) are used currently in the treatment of PD; however, no study has assessed the effects of COMT-I administration on Hcy concentrations in PD patients. We compared plasma levels of Hcy, B12, and folate in 26 PD patients treated with levodopa, 20 PD patients treated with levodopa + COMT-I, and 32 controls. No significant differences were found in vitamin B12 levels, whereas folate concentrations were significantly lower in the levodopa-treated group. Plasma Hcy was increased significantly in the two groups of PD patients and was significantly lower in the group treated with levodopa + COMT-I. Statistical analysis showed that the difference in mean Hcy levels observed among PD patients was related to the addition of COMT-I, rather than to ...Continue Reading

References

Oct 4, 1995·JAMA : the Journal of the American Medical Association·C J BousheyA G Motulsky
Nov 14, 1998·European Neurology·W KuhnT Müller
Feb 15, 2002·The New England Journal of Medicine·Sudha SeshadriPhilip A Wolf
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Frank L MastagliaByron A Kakulas
Mar 5, 2003·Journal of the Neurological Sciences·Kazuhiro NakasoKenji Nakashima
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Kurt A Jellinger
Jun 17, 2003·Acta Neurologica Scandinavica·K YasuiK Nakashima
Jul 10, 2003·Lancet Neurology·Martha Savaria Morris

❮ Previous
Next ❯

Citations

Jun 8, 2006·European Journal of Clinical Pharmacology·Thomas Müller, Wilfried Kuhn
Aug 7, 2009·Journal of Neural Transmission·Thomas Müller, Siegfried Muhlack
Apr 2, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giulio SciglianoFloriano Girotti
Sep 3, 2009·Nature Reviews. Neurology·Wandana Nanhoe-MahabierBastiaan R Bloem
Dec 24, 2009·Cardiovascular Psychiatry and Neurology·Thomas Müller
Feb 16, 2008·Proteome Science·Cornelius J WernerSabine Wolf
Oct 4, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Livrea
Jun 17, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Livrea
May 28, 2010·Neuropsychiatric Disease and Treatment·Steven F Werder
Sep 17, 2014·The International Journal of Neuroscience·Eleonora DžoljićVladimir Kostić
Mar 13, 2014·Expert Opinion on Drug Safety·Wolfgang H Jost
Dec 11, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Rima ObeidWolfgang Herrmann
Aug 6, 2016·BioMed Research International·Bilge KocerSelim Selcuk Comoglu
Dec 7, 2007·Expert Review of Neurotherapeutics·Julie Leegwater-Kim, Cheryl Waters
May 29, 2008·Expert Review of Neurotherapeutics·Thomas Müller
Apr 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Stefano ZoccolellaPaolo Livrea
Jul 10, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Roberto CeravoloUbaldo Bonuccelli
Aug 31, 2017·Journal of Movement Disorders·Joong Hyun ParkJong Sam Baik
Aug 15, 2009·Clinical Chemistry·Rima ObeidWolfgang Herrmann
Oct 30, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Stefano ZoccolellaPaolo Lamberti
Apr 3, 2020·Expert Opinion on Drug Metabolism & Toxicology·Thomas Müller
Sep 23, 2009·Expert Review of Neurotherapeutics·Olaf StangerMichael Linnebank
May 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Maria C Rodriguez-OrozJose A Obeso
Jul 16, 2019·Nutrition Research Reviews·Lauren K Murray, Nafisa M Jadavji
Feb 26, 2019·Experimental & Molecular Medicine·Tauheed HasanLaishram Rajendrakumar Singh
Feb 26, 2016·Journal of Clinical Neuromuscular Disease·Varun Shandal, Jin Jun Luo
Sep 27, 2019·Journal of Clinical Medicine·Oana Maria VantaLacramioara Perju-Dumbrava
May 10, 2019·Frontiers in Nutrition·Caterina TinelliMarco Feligioni
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna PierzchlińskaMonika Białecka
Oct 11, 2020·Neuropharmacology·Carlos G MoreiraChristian R Baumann
May 17, 2021·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Chumpol Anamnart, Ram Kitjarak
Sep 29, 2021·Basic & Clinical Pharmacology & Toxicology·Bensu KarahalilSevgi Akaydin Yardim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Padraig E O'SuilleabhainRamon Diaz-Arrastia
© 2021 Meta ULC. All rights reserved